Syn X Pharma

proteomics-based discovery of disease markers

History:

Syn X Pharma was acquired by Nanogen in 2004 and is acting as a subsidiary.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
North America

Research Focus:
Diagnostics Proteomics

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: